Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Nutrex Research Lipo-6X (January 26, 2011)

Starting date:
January 26, 2011
Posting date:
February 21, 2011
Type of communication:
Drug Recall
Natural health products
Hazard classification:
Type I
Source of recall:
Health Canada
Product Safety
General Public, Healthcare Professionals, Hospitals
Identification number:


Product contains synephrine and caffeine. According to POL-0093 Appendix B, the combination of these two ingredients may be considered to pose a serious risk to health.

Depth of distribution

National distribution to retail level.

Affected products

Nutrex Research Lipo-6X


No market authorization

Dosage form



  • Medicinal Ingredients (Serving Size: 2 Multi-Phase Capsules)
  • Synephrine HCL 20 mg,
  • Synthetic Acacia Rigidula Mimicking Complex 100 mg (Verified Grade of Activity Level: 100%), Thyroid Timulating Proprietary Matrix (B-Phenylethylamine HCL, N-Methyl-B-Phenylethylamine, Tyramine HCL, Hordenine),
  • Caffeine Anhydrous 200 mg,
  • Synthetic Guggulsterones Z&E 1:1 20 mg,
  • Phase #1 Rapid release Liquid Delivery Blend 804 mg (Glycering, Purified USP Water)

Lot or serial number

All lots within expiry


Recalling Firm
True North Nutrition
88 East Beaver Creek Road, Building A, Unit 1
Richmond Hill Ontario
Canada L4B 4A8
Marketing Authorization Holder
Not Applicable